SWEDISH MEDICAL CENTER CHERRY HILL
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $802K
- Transactions
- 140
- Companies
- 29
- Average per transaction
- $5,728
Who reported the payments
| Genmab U.S., Inc. | $252,230 |
| Acutus Medical, Inc. | $120,000 |
| Pfizer | $98,277 |
| Shockwave Medical, Inc | $46,734 |
| Med-el Corporation | $36,990 |
| Genmab A/s | $33,348 |
| Boston Scientific | $32,920 |
| Amylyx Pharmaceuticals, Inc. | $31,273 |
| Amgen | $25,247 |
| Edwards Lifesciences | $24,625 |
| Acerta Pharma LLC | $20,768 |
| Stryker | $17,441 |
| Sun Pharmaceutical Industries Inc. | $17,154 |
| Mallinckrodt Hospital Products Inc. | $8,901 |
| AVEO Pharmaceuticals, Inc. | $8,200 |
| W. L. Gore & Associates, Inc. | $5,522 |
| Mindray DS USA, Inc. | $3,792 |
| Cardiovascular Systems Inc. | $3,185 |
| Medline Industries LP | $2,879 |
| Medical Device Business Services, Inc. | $2,000 |
| Biogen | $2,000 |
| Mallinckrodt Enterprises LLC | $1,694 |
| Accuray Incorporated | $1,560 |
| Organon | $1,400 |
| Abbott | $1,346 |
| Amneal Pharmaceuticals LLC | $1,000 |
| Trireme Medical LLC | $700 |
| Stemline Therapeutics Inc. | $672 |
| CSL Behring | $38 |